Vortioxetine manufacturing process
US-9353073-B2 · May 31, 2016 · US
US10562872B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10562872-B2 |
| Application number | US-201716072596-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 6, 2017 |
| Priority date | Feb 8, 2016 |
| Publication date | Feb 18, 2020 |
| Grant date | Feb 18, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a method for synthesis of 1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]piperazine in the presence of a strong base.
Opening claim text (preview).
The invention claimed is: 1. A method for preparing 1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]piperazine, said method comprising the steps of reacting a piperazine with an electrophile in an organic solvent in the presence of a base and in the absence of a transition metal catalyst, thereby obtaining i. 1-[2-fluoro-phenyl]piperazine or 1-[2-chloro-phenyl]piperazine; or ii. 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine, wherein the electrophile is selected from the group consisting of 1, 2-di-fluorobenzene, 2-chloro-fluorobenzene, 1, 2-di-chlorobenzene, 2-(2,4-di-methyl-thiophenol-yl)-chlorobenzene, and 2-(2,4-di-methyl-thiophenol-yl)-fluorobenzene; the base has a pKa above 29 in DMSO or a pKa above 25 in THF; and the organic solvent only contains protons with a pKa above 32 in DMSO; if 1-[2-fluoro-phenyl]piperazine or 1-[2-chloro-phenyl]piperazine is obtained, reacting said 1-[2-fluoro-phenyl]piperazine or 1-[2-chloro-phenyl]piperazine with 1-sulfanyl-2,4-dimethyl-benzene, thereby obtaining 1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]piperazine; and optionally purifying the 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine. 2. The method according to claim 1 , wherein 2-(2,4-di-methyl-thiophenol-yl)-chlorobenzene or 2-(2,4-di-methyl-thiophenol-yl)-fluorobenzene has been obtained by reacting i. 1, 2-di-fluorobenzene, 2-chloro-fluorobenzene, or 1, 2-di-chlorobenzene with ii. 2,4-dimethyl-phenylsulfanyl. 3. The method according to claim 1 , wherein reacting the piperazine with the electrophile comprises the sub-steps of i) reacting the piperazine with said base and ii) reacting the product of step i) with said electrophile, and wherein sub-steps i) and ii) are performed in the indicated order. 4. The method according to claim 1 , wherein the solvent only contains protons with a pKa above 35.1 in DMSO. 5. The method according to claim 1 , wherein the solvent contains no carbonyl groups. 6. The method according to claim 1 , wherein the solvent contains no sulfoxide groups. 7. The method according to claim 1 , wherein the solvent is selected from the group consisting of ethers, alkanes, benzene and substituted benzene. 8. The method according to claim 7 , wherein the ether is selected from the group consisting of tetrahydrofuran (THF), dioxane, dimethoxyethane (DME), and 2-methyl-tetrahydrofuran (2-Me-THF). 9. The method according to claim 7 , wherein the alkane is a liquid at the reaction temperature. 10. The method according to claim 7 , wherein the alkane is methylcyclohexane. 11. The method according to claim 7 , wherein the substituted benzene is benzene substituted with one or more substituents selected from the group consisting of C1-3-alkyl and —Cl, wherein said benzene is substituted with at most 1 —Cl. 12. The method according to claim 7 , wherein the substituted benzene is selected from the group consisting of xylene, toluene and chlorobenzene. 13. The method according to claim 1 , wherein the base has a corresponding acid that has a pKa of less than 45 in THF. 14. The method according to claim 1 , wherein the base is selected from the group consisting of LiHMDS, NaHMDS, KHMDS, LiTMP, and BuLi. 15. The method according to claim 1 , wherein the base is selected from the group consisting of LiHMDS, NaHMDS, KHMDS and LiTMP. 16. The method according to claim 1 , wherein reacting the piperazine with the electrophile is performed at a temperature of at most 120° C. 17. The method according to claim 1 , wherein reacting the piperazine with the electrophile takes places for at most one week. 18. The method according to claim 1 , wherein reacting the piperazine with the electrophile takes places for 5 to 900 minutes. 19. The method according to claim 1 , wherein said 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine is obtained as a salt thereof. 20. The method of claim 1 , wherein reacting the piperazine with the electrophile is performed at a temperature of at most 110° C. 21. The method of claim 1 , wherein reacting the piperazine with the electrophile takes places for 5 to 720 minutes. 22. The method of claim 1 , wherein the solvent is selected from the group consisting of tetrahydrofuran (THF), dioxane, dimethoxyethane (DME), and 2-methyl-tetrahydrofuran (2-Me-THF), and the base is selected from the group consisting of LiHMDS, NaHMDS, KHMDS and LiTMP.
with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings · CPC title
attached in position 2 · CPC title
linked by a carbon chain containing aromatic rings · CPC title
with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines · CPC title
with the ring nitrogen atoms directly attached to carbocyclic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.